2'-C-Ethynyladenosine exhibits broad antitumor activity, particularly targeting indolent lymphoid malignancies; its anticancer mechanism involves inhibition of DNA synthesis and induction of apoptosis; it also serves as a click chemistry reagent, featuring an alkyne group that undergoes copper-catalyzed azide-alkyne cycloaddition (CuAAC) with azide-containing molecules.